Cite
HARVARD Citation
Strongman, H. et al. (2018). Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study. BMJ open diabetes research and care. 6 (1), p. . [Online].